NIH-funded research R37 grant

New MRI method to assess treatment response in brain tumors

Official title: Development of a Clinical CEST MR Fingerprinting Method for Treatment Response Assessment in Brain Metastases

Funded at Sloan-Kettering Inst Can Research · NIH-10814916 · Data updated 2026-11-12

This study is testing a new MRI method that helps doctors see how brain tumors respond to treatment by providing detailed information about the tumors, which could lead to better care for patients.

More Brain Metastases research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionSloan-Kettering Inst Can Research
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2022
Project endJuly 31, 2027
Funding year2024
Award (this year)$658,526
NIH project number5R37CA262662-03
Project IDNIH-10814916 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with brain metastases who are undergoing treatment.

Less likely to help

Patients with non-cancerous brain conditions or those not receiving treatment for brain metastases may not benefit from this research.

What this research studies

This research focuses on developing a novel MRI technique called Chemical Exchange Saturation Transfer (CEST) magnetic resonance fingerprinting to better evaluate how brain metastases respond to treatment. By using specific radio-frequency pulses, the method aims to provide detailed information about the chemical environment of tumors, including pH levels and protein concentrations. This could help distinguish between tumor progression and treatment effects, ultimately leading to more accurate assessments of patient conditions. The approach seeks to overcome current limitations in imaging quality and data processing time.

Why it matters

Potential benefit: If successful, this research could lead to more precise monitoring of brain tumor treatments, improving patient outcomes.

How similar studies have gone: Previous studies have shown promise in using CEST MRI techniques for tumor imaging, indicating potential for success in this novel application.

Where this research is happening

  • Sloan-Kettering Inst Can Research
    New York, United States
    Active

Researchers

  • Principal investigator: Cohen, Ouri — Sloan-Kettering Inst Can Research
  • Study coordinator: Cohen, Ouri

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.